Literature DB >> 20583384

Monitoring the coverage and impact of human papillomavirus vaccine - report of WHO meeting, November 2009.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583384

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN: 0049-8114


× No keyword cloud information.
  6 in total

1.  Can clinical tests help monitor human papillomavirus vaccine impact?

Authors:  Elissa Meites; Carol Lin; Elizabeth R Unger; Martin Steinau; Sonya Patel; Lauri E Markowitz; Susan Hariri
Journal:  Int J Cancer       Date:  2013-03-13       Impact factor: 7.396

2.  Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural Ethiopia.

Authors:  Sami-Ramzi Leyh-Bannurah; Christof Prugger; Maurits Nc de Koning; Hartmut Goette; Ralph J Lellé
Journal:  Infect Agent Cancer       Date:  2014-10-08       Impact factor: 2.965

3.  The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries.

Authors:  N Howard; S Mounier-Jack; K E Gallagher; S Kabakama; U K Griffiths; M Feletto; D S LaMontagne; H E D Burchett; D Watson-Jones
Journal:  Hum Vaccin Immunother       Date:  2016-05-09       Impact factor: 3.452

4.  Monitoring human papillomavirus prevalence in urine samples: a review.

Authors:  Espen Enerly; Cecilia Olofsson; Mari Nygård
Journal:  Clin Epidemiol       Date:  2013-03-12       Impact factor: 4.790

5.  Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.

Authors:  Katherine E Gallagher; Natasha Howard; Severin Kabakama; Sandra Mounier-Jack; Ulla K Griffiths; Marta Feletto; Helen E D Burchett; D Scott LaMontagne; Deborah Watson-Jones
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

Review 6.  Vaccination against HPV: boosting coverage and tackling misinformation.

Authors:  Janne Bigaard; Silvia Franceschi
Journal:  Mol Oncol       Date:  2020-10-15       Impact factor: 6.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.